Records containing: Prostate Cancer
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2021-01-05Phase II Study of the Use of Neoadjuvant Cabazitaxel With Hormonal Treatment in Patients With High Risk Operable Prostate Cancer, to Assess the Efficacy and Toxicity of Cabazitaxel, and, to Explore Potential Predictive and Prognostic Markers of Clinical Outcome
-
CLINICAL_TRIALS study record update · 2021-01-05MRI-guided Stereotactic Body Radiotherapy (SBRT) With Simultaneous Integrated Boost for Prostate Cancer
-
CLINICAL_TRIALS study record update · 2021-01-05Prostate Biopsies With Target Lesion on MRI : When Can Non-targeted Biopsies be Dispensed With
-
CLINICAL_TRIALS study record update · 2020-12-30A Phase 2 Study of TRC105 (Anti-endoglin Antibody) With Abiraterone and With Enzalutamide in Metastatic, Castration Resistant Prostate Cancer Patients Progressing on Therapy
-
CLINICAL_TRIALS study record update · 2020-12-24PEAX: Men With Metastatic Castrate-Resistant Prostate Cancer Treated With Either Sipuleucel-T (Provenge®), Abiraterone Acetate (Zytiga®) or Enzalutamide (Xtandi®) Undergoing Cardiopulmonary EXercise Testing
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2020-12-22Evaluation of Gallium-68 HBED-CC-PSMA Imaging in Prostate Cancer Patients
-
CLINICAL_TRIALS study record update · 2020-12-22A Randomised Feasibility Trial to Investigate the Timing of HDR Brachytherapy With EBRT in Intermediate and High Risk Localised Prostate CAncer Patients and Its Effects on Toxicity and Quality of Life
-
CLINICAL_TRIALS study record update · 2020-12-21Modeling Clinical Failure in Prostate Cancer Patients Based on a Two-stage Statistical Model
-
CLINICAL_TRIALS study record update · 2020-12-21Ability of Cardio Q for Prediction of Hypotension After Postural Change in Robot-Assisted Laparoscopic Radical Prostatectomy
-
CLINICAL_TRIALS study record update · 2020-12-21A Single Blind, Two-Stage Dose Finding Study to Evaluate the Safety, Tolerability and Efficacy of a Single Liproca® Depot Injection Into the Prostate in Patients With Localized Prostate Cancer, Assigned to Active Surveillance Who Are at High Risk for Disease Progression (Followed by an Open Label Extension With a Repeat Injection (Optional)).
-
CLINICAL_TRIALS study record update · 2020-12-19A Phase I/II Open-label Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MCS110 in Patients With Prostate Cancer and Bone Metastases
-
CLINICAL_TRIALS study record update · 2020-12-19An Open Label, Single Arm, Phase Ib Dose Finding Study of i.v. Panobinostat (LBH589) With Docetaxel and Prednisone in Patients With Hormone Refractory Prostate Cancer
-
CLINICAL_TRIALS study record update · 2020-12-17Pelvic Health and Physical Therapy to Improve Lives of Prostate Cancer Patients
-
CLINICAL_TRIALS study record update · 2020-12-17Hypofractionated Accelerated Radiotherapy for Low Risk Localized Prostate Cancer (pHART 3)
-
CLINICAL_TRIALS study record update · 2020-12-17Incidence and Clinical-pathological Characteristics of Prostate Cancer in Kidney Transplants Recipients ( KTRs)
-
CLINICAL_TRIALS study record update · 2020-12-16Multi-Center Randomized Clinical Two Arm Intervention Study Evaluating Irreversible Electroporation for the Ablation of Localized Prostate Cancer
-
CLINICAL_TRIALS study record update · 2020-12-14Registry of Irreversible Electroporation for the Ablation of Prostate Cancer With Use of Nanoknife Device; A Multi-Center, International Registry to Evaluate the Treatment of Prostate Cancer in Terms of Recurrence, Functional Outcomes and Safety.
-
CLINICAL_TRIALS study record update · 2020-12-11High Dose Rate (HDR)Prostate Brachytherapy With Vitesse tm
-
CLINICAL_TRIALS study record update · 2020-12-10Gallium-68 PSMA-11 PET in Intermediate to High-risk Preprostatectomy Patients
-
CLINICAL_TRIALS study record update · 2020-12-09A Phase IV Interventional Safety Study of ELIGARD® in Prostate Cancer Patients in Asia (ELIGANT)
-
CLINICAL_TRIALS study record update · 2020-12-09A Phase II Open-label, Parallel Group Study of Abiraterone Acetate Plus Prednisone in African American and Caucasian Men With Metastatic Castrate-resistant Prostate Cancer
-
CLINICAL_TRIALS study record update · 2020-12-09A Multicentric, Multinational (China and Russia), Randomised, Open, Controlled Study of Immediate 9 Months Adjuvant Hormone Therapy With Triptorelin 11.25 mg Versus Active Surveillance After Radical Prostatectomy in High Risk Prostate Cancer Patients
-
CLINICAL_TRIALS study record update · 2020-12-07PET/MRI Study of Men With Highly Suspicious MRI Lesions That Showed no Clinically Significant Prostate Cancer Following MRI Fusion Targeted Biopsy
-
CLINICAL_TRIALS study record update · 2020-12-07Improving Bio-availability of the Expensive Oral Oncolytic Drug Abiraterone by Food Intake
-
CLINICAL_TRIALS study record update · 2020-12-02A Pragmatic Randomised, Multicentre Trial Comparing 4-weekly Versus 12-weekly Administration of Bone-targeted Agents in Patients With Bone Metastases From Either Castration-resistant Prostate Cancer or Breast Cancer - The REaCT-BTA Study